Home
>
National Drug Code (NDC)
>
Renagel
Renagel - 58468-0021-3 - (Renagel)
Drug Information of Renagel
| Product NDC: | 58468-0021 |
| Proprietary Name: | Renagel |
| Non Proprietary Name: | Renagel |
| Active Ingredient(s): | 800 mg/1 & nbsp; Renagel |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Renagel
| Product NDC: | 58468-0021 |
| Labeler Name: | Genzyme Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021179 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20080606 |
Package Information of Renagel
| Package NDC: | 58468-0021-3 |
| Package Description: | 30 TABLET in 1 BOTTLE, PLASTIC (58468-0021-3) |
NDC Information of Renagel
| NDC Code | 58468-0021-3 |
| Proprietary Name | Renagel |
| Package Description | 30 TABLET in 1 BOTTLE, PLASTIC (58468-0021-3) |
| Product NDC | 58468-0021 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Renagel |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20080606 |
| Marketing Category Name | NDA |
| Labeler Name | Genzyme Corporation |
| Substance Name | SEVELAMER HYDROCHLORIDE |
| Strength Number | 800 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Phosphate Binder [EPC],Phosphate Chelating Activity [MoA] |
